{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T12:38:05Z","timestamp":1777293485345,"version":"3.51.4"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T00:00:00Z","timestamp":1721347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Kyowa Kirin UK"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s00198-024-07095-4","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T12:01:32Z","timestamp":1721390492000},"page":"2055-2060","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Longitudinal assessment of physical function in adults with X-linked hypophosphatemia following initiation of burosumab therapy"],"prefix":"10.1007","volume":"35","author":[{"given":"Giorgio","family":"Orlando","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Roy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"Bubbear","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Keen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Kassim","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1094-9183","authenticated-orcid":false,"given":"Alex","family":"Ireland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,7,19]]},"reference":[{"key":"7095_CR1","doi-asserted-by":"publisher","first-page":"e871","DOI":"10.1210\/clinem\/dgz203","volume":"105","author":"S Hawley","year":"2020","unstructured":"Hawley S, Shaw NJ, Delmestri A, Prieto-Alhambra D, Cooper C, Pinedo-Villanueva R, Javaid MK (2020) Prevalence and mortality of individuals with X-linked hypophosphatemia: a United Kingdom real-world data analysis. J Clin Endocrinol Metab 105:e871-878","journal-title":"J Clin Endocrinol Metab"},{"key":"7095_CR2","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.bone.2016.11.019","volume":"95","author":"T Boukpessi","year":"2017","unstructured":"Boukpessi T, Hoac B, Coyac BR et al (2017) Osteopontin and the dento-osseous pathobiology of X-linked hypophosphatemia. Bone 95:151\u2013161","journal-title":"Bone"},{"key":"7095_CR3","doi-asserted-by":"publisher","first-page":"R13","DOI":"10.1530\/EC-13-0103","volume":"3","author":"A Linglart","year":"2014","unstructured":"Linglart A, Biosse-Duplan M, Briot K et al (2014) Therapeutic management of hypophosphatemic rickets from infancy to adulthood. Endocr Connect 3:R13-30","journal-title":"Endocr Connect"},{"key":"7095_CR4","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1007\/s00198-022-06318-w","volume":"33","author":"G Orlando","year":"2022","unstructured":"Orlando G, Bubbear J, Clarke S, Keen R, Roy M, Anilkumar A, Schini M, Walsh JS, Javaid MK, Ireland A (2022) Physical function and physical activity in adults with X-linked hypophosphatemia. Osteoporos Int 33:1485\u20131491","journal-title":"Osteoporos Int"},{"key":"7095_CR5","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1002\/jbmr.3475","volume":"33","author":"KL Insogna","year":"2018","unstructured":"Insogna KL, Briot K, Imel EA et al (2018) A randomized, double-blind, placebo-controlled, phase 3 trial evaluating the efficacy of burosumab, an anti-FGF23 antibody, in adults with x-linked hypophosphatemia: week 24 primary analysis. J Bone Miner Res 33:1383\u20131393","journal-title":"J Bone Miner Res"},{"key":"7095_CR6","doi-asserted-by":"crossref","unstructured":"Briot K, Portale AA, Brandi ML et al (2021) Burosumab treatment in adults with X-linked hypophosphataemia: 96-week patient-reported outcomes and ambulatory function from a randomised phase 3 trial and open-label extension. RMD Open 7(3):e001714","DOI":"10.1136\/rmdopen-2021-001714"},{"key":"7095_CR7","doi-asserted-by":"crossref","unstructured":"Kamenicky P, Briot K, Brandi ML et al (2023) Benefit of burosumab in adults with X-linked hypophosphataemia (XLH) is maintained with long-term treatment. RMD Open 9(1):e002676","DOI":"10.1136\/rmdopen-2022-002676"},{"key":"7095_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s13023-016-0528-6","volume":"11","author":"MK Javaid","year":"2016","unstructured":"Javaid MK, Forestier-Zhang L, Watts L et al (2016) The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseases. Orphanet J Rare Dis 11:150","journal-title":"Orphanet J Rare Dis"},{"key":"7095_CR9","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1172\/JCI109239","volume":"62","author":"TJ Fuller","year":"1978","unstructured":"Fuller TJ, Nichols WW, Brenner BJ, Peterson JC (1978) Reversible depression in myocardial performance in dogs with experimental phosphorus deficiency. J Clin Invest 62:1194\u20131200","journal-title":"J Clin Invest"},{"key":"7095_CR10","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1093\/gerona\/glx223","volume":"73","author":"A Hartley","year":"2018","unstructured":"Hartley A, Gregson CL, Hannam K, Deere KC, Clark EM, Tobias JH (2018) Sarcopenia is negatively related to high gravitational impacts achieved from day-to-day physical activity. J Gerontol A Biol Sci Med Sci 73:652\u2013659","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"7095_CR11","first-page":"62","volume":"26","author":"H Finol","year":"2001","unstructured":"Finol H, De Venanzi F, Pereyra B, Alfonso C, S\u00e1nchez J (2001) Effects of phosphorus deficiency on the ultrastructure of the rat fast twitch skeletal muscle. Interciencia 26:62\u201366","journal-title":"Interciencia"},{"key":"7095_CR12","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1172\/JCI108343","volume":"57","author":"TJ Fuller","year":"1976","unstructured":"Fuller TJ, Carter NW, Barcenas C, Knochel JP (1976) Reversible changes of the muscle cell in experimental phosphorus deficiency. J Clin Invest 57:1019\u20131024","journal-title":"J Clin Invest"},{"key":"7095_CR13","doi-asserted-by":"publisher","first-page":"e1249","DOI":"10.1210\/clinem\/dgab739","volume":"107","author":"MK Javaid","year":"2022","unstructured":"Javaid MK, Ward L, Pinedo-Villanueva R, Rylands AJ, Williams A, Insogna K, Imel EA (2022) Musculoskeletal features in adults with X-linked hypophosphatemia: an analysis of clinical trial and survey data. J Clin Endocrinol Metab 107:e1249\u2013e1262","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-024-07095-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-024-07095-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T10:02:36Z","timestamp":1729677756000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-024-07095-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,19]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["7095"],"URL":"https:\/\/doi.org\/10.1007\/s00198-024-07095-4","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,19]]},"assertion":[{"value":"22 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GO and AI were supported by research funding from Kyowa Kirin. JB has received honoraria from Kyowa Kirin. MR,, SC, RK, and MKJ declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}